[go: up one dir, main page]

WO2004093876A3 - Procede et composition pour reguler des pathogenes oraux - Google Patents

Procede et composition pour reguler des pathogenes oraux Download PDF

Info

Publication number
WO2004093876A3
WO2004093876A3 PCT/US2004/008616 US2004008616W WO2004093876A3 WO 2004093876 A3 WO2004093876 A3 WO 2004093876A3 US 2004008616 W US2004008616 W US 2004008616W WO 2004093876 A3 WO2004093876 A3 WO 2004093876A3
Authority
WO
WIPO (PCT)
Prior art keywords
disorders
derivative
agent
composition containing
treating oral
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2004/008616
Other languages
English (en)
Other versions
WO2004093876A2 (fr
Inventor
Christine D Wu
Douglas Kinghorn
Sara Kate Roberts
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Illinois at Urbana Champaign
University of Illinois System
Original Assignee
University of Illinois at Urbana Champaign
University of Illinois System
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Illinois at Urbana Champaign, University of Illinois System filed Critical University of Illinois at Urbana Champaign
Priority to US10/551,639 priority Critical patent/US20070098649A1/en
Publication of WO2004093876A2 publication Critical patent/WO2004093876A2/fr
Anticipated expiration legal-status Critical
Publication of WO2004093876A3 publication Critical patent/WO2004093876A3/fr
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4741—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having oxygen as a ring hetero atom, e.g. tubocuraran derivatives, noscapine, bicuculline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/65—Tetracyclines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

L'invention concerne une composition et un procédé pour réguler des pathogènes oraux ou tout autre pathogène humain. La composition et le procédé de l'invention comprennent l'utilisation d'un antimicrobien ou d'un antibiotique et de la berbérine en tant qu'agents actifs pour traiter des mammifères, en particulier des êtres humains.
PCT/US2004/008616 2003-04-03 2004-03-22 Procede et composition pour reguler des pathogenes oraux Ceased WO2004093876A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US10/551,639 US20070098649A1 (en) 2004-03-22 2004-03-22 Method and composition for controlling oral pathogens

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US46018703P 2003-04-03 2003-04-03
US60/460,187 2003-04-03

Publications (2)

Publication Number Publication Date
WO2004093876A2 WO2004093876A2 (fr) 2004-11-04
WO2004093876A3 true WO2004093876A3 (fr) 2005-10-13

Family

ID=33310718

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2004/008616 Ceased WO2004093876A2 (fr) 2003-04-03 2004-03-22 Procede et composition pour reguler des pathogenes oraux

Country Status (1)

Country Link
WO (1) WO2004093876A2 (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1787627A1 (fr) * 2005-11-17 2007-05-23 3M Innovative Properties Company Materiau d`empreinte dentaire antimicrobien
CA2766834C (fr) * 2009-06-30 2017-04-25 Derman Biomedicine Co. Ltd. Compositions contenant de la berberine ou des analogues de celle-ci pour traiter l'acne rosacee ou des troubles cutanes associes a une rougeur faciale
CN102079765B (zh) * 2010-12-15 2013-03-20 西南大学 9-o-糖苷-小檗碱盐及其制备方法和应用
CN105497028A (zh) * 2015-12-15 2016-04-20 上海壹志医药科技有限公司 小檗红碱的药物用途
WO2017143361A1 (fr) * 2016-02-18 2017-08-24 Drabinsky Michael Earl Traitement de maladies causées par les spirochètes
BR112019020225A2 (pt) * 2017-03-28 2020-04-22 IRP Health Pty Ltd alcaloides berberina na prevenção e/ou tratamento de doença intestinal
CN110372690B (zh) 2018-04-13 2021-03-30 中国医学科学院药物研究所 R10与r11连接的亲水性小檗碱型衍生物及其制备药物的应用

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5741138A (en) * 1996-08-12 1998-04-21 The Procter & Gamble Company Oral compositions
WO1998044926A1 (fr) * 1997-04-04 1998-10-15 Optiva Corp. Compositions antimicrobiennes
US6248309B1 (en) * 1997-04-04 2001-06-19 Optiva Corporation Gums containing antimicrobial agents
WO2002091848A1 (fr) * 2001-05-15 2002-11-21 The Procter & Gamble Company Compositions de confiserie

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5741138A (en) * 1996-08-12 1998-04-21 The Procter & Gamble Company Oral compositions
WO1998044926A1 (fr) * 1997-04-04 1998-10-15 Optiva Corp. Compositions antimicrobiennes
US6248309B1 (en) * 1997-04-04 2001-06-19 Optiva Corporation Gums containing antimicrobial agents
WO2002091848A1 (fr) * 2001-05-15 2002-11-21 The Procter & Gamble Company Compositions de confiserie

Also Published As

Publication number Publication date
WO2004093876A2 (fr) 2004-11-04

Similar Documents

Publication Publication Date Title
AU2001271545A1 (en) Promoting whole body health
WO2002002063A3 (fr) Renforcement de la sante globale du corps
WO2004005286A3 (fr) Inhibiteurs viraux
WO2004013300A3 (fr) Composes contenant un bicyclo[4.2.1]nonane, utilises dans le traitement des infections causees par les flaviviridae
WO2003000699A8 (fr) Derives de 1-oxa-2,8-diazaspiro[4,5]dec-2-ene servant d'antalgiques
WO2001045679A3 (fr) Utilisation d'agents chimiotherapeutiques
WO2002072031A3 (fr) Composes de tetracycline substitue utilises en tant qu'antifongiques synergiques
WO2005046618A3 (fr) Methodes de traitement de l'eczema
AU2003241345A1 (en) Use of mastic and its components for the control of microbial infections
PL1638938T3 (pl) Związki, kompozycje i sposoby do leczenia i zapobiegania infekcjom ortopokswirusami i powiązanym chorobom
EP1594444A4 (fr) Methodes et compositions destinees au traitement et a la prevention d'infections a staphylocoque ou autres infections bacteriennes
WO2001028491A3 (fr) Procede et composition utilises afin de traiter les affections dermatologiques
WO2004110380A3 (fr) Traitement des maladies a mediation immunologique au moyen de composes a base de vitamine d active, seuls ou en association avec d'autres agents therapeutiques
CA2530474A1 (fr) Remede contre la sarcoidose et procede de traitement associe
WO2004110151A8 (fr) Traitement du cancer au moyen de composes de vitamine d actifs associes a des agents et a des traitements radiotherapeutiques
EP3305305A3 (fr) Compositions à base de silicate et procédés de traitement
AU2003270498A1 (en) Topical veterinary compositions and methods for the treatment and prevention of infection
AU2003202153A1 (en) Composition for preventing or treating mastitis of dairy cattle
WO2003101382A3 (fr) Composes permettant de traiter l'anthrax et d'inhiber le facteur letal
WO2004093876A3 (fr) Procede et composition pour reguler des pathogenes oraux
WO2003061704A3 (fr) Traitement combine d'infections bacteriennes
WO2002062334A3 (fr) Composes de chimioprevention des cancers et compositions et procedes de traitement des cancers
SE0004101D0 (sv) New use
WO2003024996A3 (fr) Macrocycles antibacteriens
WO2002070638A3 (fr) Composition et procedes fondes sur une huile essentielle antimicrobienne extraite de coleus forskohlii

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): BW GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
122 Ep: pct application non-entry in european phase
WWE Wipo information: entry into national phase

Ref document number: 2007098649

Country of ref document: US

Ref document number: 10551639

Country of ref document: US

WWP Wipo information: published in national office

Ref document number: 10551639

Country of ref document: US